Quick Answer
Aclaris Therapeutics, Inc. reported Total Revenue of $7.83 million for fiscal year 2025.
Aclaris Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $7.83M | -58.2% |
| 2024 | $18.72M | -40.1% |
| 2023 | $31.25M | +5.0% |
| 2022 | $29.75M | +340.1% |
| 2021 | $6.76M | +4.3% |
| 2020 | $6.48M | +53.3% |
| 2019 | $4.23M | -31.3% |
| 2018 | $6.15M | +265.5% |
| 2017 | $1.68M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.30M | -24.1% | +85.6% |
| June 30, 2025 | $1.78M | -35.8% | +22.1% |
| March 31, 2025 | $1.46M | -39.3% | -66.5% |
| September 30, 2024 | $4.35M | -53.2% | +57.1% |
| June 30, 2024 | $2.77M | +48.0% | +15.3% |
| March 31, 2024 | $2.40M | -5.1% | -74.2% |
| September 30, 2023 | $9.28M | -51.2% | +396.6% |
| June 30, 2023 | $1.87M | +22.3% | -26.1% |
- Aclaris Therapeutics, Inc. showed a decrease of -58.2% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, Aclaris Therapeutics, Inc.’s total revenue has grown by 365.0% (from $1.68 million to $7.83 million).
- The most recent figure is from Aclaris Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: